Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.

@article{Ummanni2008ProhibitinIB,
  title={Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.},
  author={Ramesh Ummanni and Heike P Junker and Uwe Zimmermann and Simone Venz and Steffen Teller and J{\"u}rgen Giebel and Christian Scharf and Christian Woenckhaus and Frank Dombrowski and R. {\'A}lvarez-Sala Walther},
  journal={Cancer letters},
  year={2008},
  volume={266 2},
  pages={171-85}
}
Prostate cancer (PCA) is the most common type of cancer found in men of western countries and is the leading cancer death next to lung cancer and colorectal cancer. Prostate-specific antigen (PSA) test is an established diagnostic tool for PCA detection, but confirmation of diagnosis by histopathological evaluation of prostate needle biopsies is performed. To define protein expression pattern of prostate biopsies, in the present study we investigated biopsy samples from benign prostate… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 37 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 53 references

Prohibitin

  • S. C. Gamble, D. Chotai, +8 authors C. L. Bevan
  • a protein downregulated by androgens, represses…
  • 2007

A comprehensive proteome map of growing Bacillus subtilis cells

  • D. F. Gleason, G. T. Mellinger
  • 2004

Similar Papers

Loading similar papers…